HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Osimertinib Mesylate

HCID 78357807
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1421373-66-1
Standard SMILES
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O
InChIKey
FUKSNUHSJBTCFJ-UHFFFAOYSA-N
Molecular formula
C29H37N7O5S
Average molar mass
595.7 g/mol
Monoisotopic mass
595.25768848

Overview

Osimertinib mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. It is used for treatment of EGFR T790M mutation positive non-small cell lung cancer. It has a role as an antineoplastic agent and an epidermal growth factor receptor antagonist. It contains an osimertinib(1+).

Names & identifiers

Preferred name
Osimertinib Mesylate
IUPAC
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid
English name
Osimertinib mesylate
Molecular formula
C29H37N7O5S
Molecular weight
595.72

Names & synonyms

Osimertinib mesylate1421373-66-1AZD-9291 mesylateAZD9291 mesylateMereletinib mesylateosimertinib mesilateMereletinib mesilateRDL94R2A162-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-, methanesulfonate (1:1)CHEBI:90948DTXSID101027822N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1)
Show more names
OsimertinibN-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonateOsimertinib d6Osimertinib Mesylate APIOsimertinib methanesulfonateOsimertinib (AZD9291) mesylateN-[2-(2-dimethylaminoethylmethylamino)-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide mesylate salt
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1)N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1)RefChem:58258DTXCID601513393AZD-9291 (Mesylate)TagrissoOsimertinib mesylate [USAN]AZD 9291 mesylate

Properties

Computed structural propertiesFilling in

Topological polar surface area
150 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
10
Rotatable bonds
10
Heavy atoms
42
Formal charge
0
Complexity
845

Experimental & physicochemical properties

Human Drugs · 3 items

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
232 °C · >232°C (dec.)
storage temp.
-20 °C · -20°C Freezer, Under inert atmosphere
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
color
Off-White to Yellow
InChIKey
FUKSNUHSJBTCFJ-UHFFFAOYSA-N
SMILES
S(O)(=O)(=O)C.CN1C2=CC=CC=C2C(C2C=CN=C(NC3C=C(NC(=O)C=C)C(N(C)CCN(C)C)=CC=3OC)N=2)=C1
FDA UNII
94 R2A16 · RDL94R2A16
NCI Dictionary of Cancer Terms
osimertinib mesylate; Tagrisso
NCI Drug Dictionary
osimertinib mesylate
ATC code

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (75%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P263, P264, P270, P272, P273, P280, P301+P317, P302+P352, P318, P319, P321, P330, P333+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (75%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Osimertinib mesylate

vLess-DILI-concern

4

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Safety data

hs_code
29339900
Signal word
Danger
Symbol(GHS)
GHS08,GHS07,GHS09
Hazard statements
H317-H372-H410-H400-H361-H302
Precautionary statements
P201-P202-P281-P308+P313-P405-P501-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P260-P264-P270-P314-P501-P264-P270-P301+P312-P330-P501-P273-P391-P501-P273-P391-P501

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.

Applications · 3 items

DescriptionOsimertinib is active against exon 19 deletions, exon 21 mutations, and also the exon 20 T790M mutations. It is preferentially selective for mutated EGFR, and therefore toxicity at therapeutic doses is lower than for first- and second-generation agents. Notably, osimertinib is able to cross the blood-brain barrier, making it active against disease in the CNS.

UsesOsimertinib mesylate (AZD9291) is the mesylate form of osimertinib, which is an oral, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug.

General DescriptionClass: receptor tyrosine kinaseTreatment: NSCLC Oral bioavailability = 70%Elimination half-life = 48 hProtein binding = 94.7%

Upstream & downstream products

Upstream raw materials

Mutated EGFR-IN-1AZD-9291N,N-DiisopropylethylamineEthyl acetateEthanolAcryloyl chlorideMethanesulfonic acid

Additional notes

ChEBI: A methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. Used for treatment of EGFR T790M mutation positive non-small cell lung cancer.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1421373-66-1
PubChem CID
78357807
DTXSID
DTXSID101027822
ChEMBL
CHEMBL3545063
ChEBI
CHEBI:90948
UNII
RDL94R2A16
EC Number
806-779-0
1 EB04 · L01EB04
Symbol(GHS)
8 · GHS08,GHS07,GHS09
Signal word
Danger
Hazard statements
317 · H317-H372-H410-H400-H361-H302
Precautionary statements
201 · P201-P202-P281-P308+P313-P405-P501-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P260-P264-P270-P314-P501-P264-P270-P301+P312-P330-P501-P273-P391-P501-P273-P391-P501
HS Code
29339900 · 29339900
Definition